Friday, March 14, 2025 | 09:52 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap (    %)
                             
Nifty Smallcap (    %)
                             
Nifty Bank (    %)
                             
Home / Markets / Aurobindo Pharma Ltd / Announcements / BSE

Aurobindo Pharma Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

02:35 PM, 5th Dec 2024

We enclose a copy of the press release that is being issued by the Company in connection with USFDA approval for Pazopanib Tablets 200 mg received by Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company

More Aurobindo Pharma Ltd Announcements

    View more
    HOT STOCKS
    TOP SECTIONS
    KEY EVENTS
    Copyrights © 2025 Business Standard Private Ltd. All rights reserved
    LinkedIN Icon